Sign Out
This medicinal product is not recommended in pregnant and breast-feeding women.
Pregnancy: Topical administration of corticosteroids to pregnant animals caused abnormalities of foetal development, but the relevance of this finding to use of corticosteroids in humans has not been established.
However, neomycin present in maternal blood may cross the placenta, thus increasing the risk of foetal toxicity. Consequently, the use of Betnovate-N cream is not recommended in pregnant women.
Breast-feeding: The safety of Betnovate-N cream has not been determined in breast-feeding women. It is not known whether topical corticosteroids could cause sufficient systemic absorption to result in detectable amounts in breast milk.
Consequently, the use of Betnovate-N cream in breast-feeding women is not recommended.
Fertility: No data are available on the effects of Betnovate-N cream on human fertility.
